News & Events

November 28, 2023

AbTherx Appoints David Meininger, PhD, MBA as Chief Business Officer

Biopharma executive with proven track record brings substantial strategy, business development, and licensing experience to AbTherx leadership team Mountain View, Calif. – Nove... Read More »

August 16, 2023

AbTherx Appoints Gavin Thurston, PhD, as Scientific Advisor

Former Regeneron Oncology Leader Joins AbTherx to Advance its Antibody Discovery Platform Mountain View, Calif. – August 16, 2023 – AbTherx, a privately held biotech company wi... Read More »

June 7, 2023

AbTherx Launches a Next-Generation Antibody Discovery Platform

The company brings together a proven team and novel technologies to increase efficiencies in antibody discovery Mountain View and San Diego, Calif. – June 7, 2023 – AbTherx, In... Read More »

June 7, 2023

AbTherx Announces License Agreement with Gilead

License from Gilead grants AbTherx worldwide rights to a novel human therapeutic antibody discovery platform Mountain View and San Diego, Calif. – June 7, 2023 – AbTherx, Inc.,... Read More »